Download the SITC 2018 Meeting App and get the most out of your 33rd Annual Meeting & Pre-Conference Programs experience.
Indianapolis | Minneapolis | Seattle New York City | Louisville, Ky. | Pittsburgh
The Society for Immunotherapy of Cancer’s new online activity explains cancer immunotherapy and the immune system to patients.
Join a SITC Professional Interest Community
Create new collaborations, build your professional network and discuss the latest research trends in SITC Professional Interest Communities.
The Journal for ImmunoTherapy of Cancer (JITC) received its first impact factor of 8.374! JITC’s impact factor ranks in the top 8 percent of all journals published in the categories of oncology and immunology.
See members discuss the benefits of a SITC membership in this new video.
Explore resources and educational opportunities for cancer patients and those who advocate for them.
Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.
Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.
Welcome Silvia (Dr. Guglietta). Glad that you are here! Priscila ------------------------------ Priscila Goncalves Associate Director Center for Novel Cancer Therapies Northwell Health - Monter Cancer Center Lake Success, NY ----------------------- ...
Hi everyone, Excited to be part of this group and hope to share ideas and find collaborations. I am a mucosal Immunologist and I am working at the University of South Carolina. I am interested in cancer of the digestive tract and microbiota. ------------------------------ ...
Dear colleagues, Dear participants,
I would like to invite you to attend and participate actively in our
ISOBM (International Society of Oncology and BioMarkers) 2018 CONGRESS, to be held in Hamburg, Germany, on November 24 - 27, 2018. ...
Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com